Skip to main content

Nader Francois's Form 4/A amendment

Amended

Tourmaline Bio, Inc. (TRML) · filed Sep 13, 2022

Accession no.
0000899243-22-030924
Filed
Sep 13, 2022
Trade date
Jul 19-25, 2022
Filing delay
56 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Jul 25, 2022

This filing lists 7 non-derivative transactions and 0 derivative transactions. Open-market purchases total $500.0K. It was filed 56 days after the trade.

This amendment replaces 0000899243-22-026684 (filed Jul 25, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Nader FrancoisCIK 0001365343Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 19, 2022Common StockPPurchaseAcquired+50,000$3.52+$176,00050,000Direct
Jul 20, 2022Common StockPPurchaseAcquired+52,000$3.62+$188,240102,000Direct
Jul 21, 2022Common StockJOtherDisposed−248,432$0.00$0147,255Indirect
Jul 21, 2022Common StockJOtherAcquired+248,432$0.00$0248,432Indirect
Jul 21, 2022Common StockPPurchaseAcquired+36,500$3.72+$135,780138,500Direct
Jul 25, 2022Common StockJOtherDisposed−138,500$0.00$00Direct
Jul 25, 2022Common StockJOtherAcquired+138,500$0.00$0386,932Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)